Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zymeworks Inc (NY: ZYME )

N/A UNCHANGED
Last Price Updated: 7:00 PM EST, Dec 15, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Zymeworks Inc

< Previous 1 2 3 4 5 6 7 Next >
Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Via Benzinga
Next-Gen Winners: 7 Tech Stocks Set to Dominate the Decade
Explore top tech stocks to dominate the decade, with their fundamental leading in information technology, finance, and health care. 
Via InvestorPlace
ZYME Stock Earnings: Zymeworks Beats EPS, Beats Revenue for Q4 2023
ZYME stock results show that Zymeworks beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List
Undervalued small-cap stocks are great for investors seeking options for upside potential, typically at a cheap share price. 
Via InvestorPlace
Last Call! 7 Small-Cap Stocks Ready to Explode in Value
Discover the small-cap stocks in the telecommunications, biotech, research, silver, transportation, and trading, ready to explode in value. 
Via InvestorPlace
Recap: Zymeworks Q3 Earnings
Via Benzinga
Earnings Scheduled For March 6, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. 
Via Benzinga
Zymeworks - Analysts Project A Big Turnaround
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. 
Via Talk Markets
7 Small-Cap Stocks With Significant Upside Potential in 2024
Dive into small-cap stocks for a mix of stability & growth, wagering on potential leaders before the market catches on. 
Via InvestorPlace
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry. 
Via InvestorPlace
3 Top Stocks to Buy This Winter for Sizzling Summer Gains
With economic momentum accelerating, these three top stocks flying under Wall Street's radar seem poised for sizzling summer gains. 
Via InvestorPlace
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
$10K to $100K: Small-Cap Marvels With Massive Upside
Transform $10K to $100K with top small-cap stocks. Discover market marvels with massive upside for savvy investors. 
Via InvestorPlace
Small-Cap Sensations: 3 Stocks Predicted for Massive Growth in 2024
These three small-cap stocks have massive return potential in 2024 and beyond, according to analyst forecasts and broader industry trends. 
Via InvestorPlace
From $10k to $100k in 5 years: 3 Small-Cap Stocks to Make a Fortune
Are you looking for small-cap stocks to get rich? Turn $10k to $100k in 5 years in the stock market with these stocks. 
Via InvestorPlace
Want to Turn Spare Change Into $1,000? Buy These 3 Stocks Now
Three high conviction stocks seem perfect for opportunistic investors and could quickly transform spare change into four-figure returns. 
Via InvestorPlace
Next Wave Biotech: 3 Stocks Poised for Breakthrough Success
The overall sector may be struggling after COVID, but there's still great potential in these three biotech stocks. 
Via InvestorPlace
Exposures COVID-19
The 7 Best Bargain Growth Stocks to Buy Before 2024
These bargain growth stocks offer significant upside potential alongside decent margins of safety, for those seeking impressive value. 
Via InvestorPlace
5 Value Stocks In The Healthcare Sector
Via Benzinga
3 Beaten-Down Stocks to Buy for 1,000% Upside in Five Years
Many stocks now trade at tempting valuations, and these three beaten-down stocks could soar 1,000% within five years. 
Via InvestorPlace
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments. 
Via InvestorPlace
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Earnings Scheduled For November 7, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term. 
Via InvestorPlace
7 Small-Cap Stocks to Buy Before the Breakout
If you don’t mind the extreme risks involved, growth investors should target these ideas for best small cap stocks to buy. 
Via InvestorPlace
5 Value Stocks In The Healthcare Sector
Via Benzinga
2 Biotech Stocks That Could Make You Richer
These biotech companies are seeing a spike in revenue growth. 
Via The Motley Fool
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.